| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| GATA3 |
Th2-cells |
Source: late Th2 Genotype: wildtype |
Permissive
Robust
|
Mus musculus |
GSE109107
...
|
MA0037.3
|
| GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
| GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-Mock-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
| GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
| GATA3 |
pro-T-tumor derived (Scid.adh.2c2 cells) |
Treatment: Transduced with pMxs-PU.1-hNGFR Strain: CB17-Prkdc<scid> mice |
Permissive
Robust
|
Mus musculus |
GSE93755
...
|
MA0037.3
|
| GATA3 |
ILC2 (type 2 Innate lympoid cells) |
Growth: with IL-2/IL-7/IL-33 for 4 weeks, and withour IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung |
Permissive
Robust
|
Mus musculus |
GSE111871
...
|
MA0037.3
|
| GATA3 |
ILC2 (type 2 Innate lympoid cells) |
Growth: with IL-2/IL-7/IL-33 for 4 weeks, and with IL-33 for a week Source: Lung ILC2 Genotype: wildtype Strain: C57BL/6 Tissue: Lung |
Permissive
Robust
|
Mus musculus |
GSE111871
...
|
MA0037.3
|
| GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: with Estrogen; |
Permissive
Robust
|
Homo sapiens |
GSE117492
...
|
MA0037.3
|
| GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
Treatment: with Estrogen +1,6-Hexanediol; |
Permissive
|
Homo sapiens |
GSE117492
...
|
MA0037.3
|
| GATA3 |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BST
|
MA0037.3
|
Showing 10 records in page 395
from 963 pages